For Immediate Release
Prodesse announces release of reagents for detection of newly discovered human metapneumovirus
WAUKESHA, WI (March 8, 2006) – Prodesse, Inc. announced today that it has released reagents for sale to CLIA laboratories who can incorporate them into their development and validation of Real Time PCR assays which can be used to detect the newly discovered human metapneumovirus (hMPV). Patent rights to hMPV are held by ViroNovative BV, Netherlands, which has licensed Prodesse to produce reagents to detect the human metapneumovirus (hMPV) analyte. Prodesse currently has the only commercially available licensed PCR reagents for labs to use in assays they develop to detect hMPV.
About Prodesse
Prodesse is a biotechnology company focused on developing molecular diagnostic reagents for a variety of infectious disease applications. The company’s products are designed based on a combination of Prodesse’s patented technologies and other licensed technologies. Prodesse sells research use only kits worldwide, CE Marked in vitro diagnostic kits outside the US , FDA 510(k) cleared products worldwide and analyte specific reagents in the US . Analyte specific reagents can be used by CLIA certified laboratories to develop assays for detecting infectious organisms. The company’s products can be used on multiple nucleic acid extraction and PCR detection platforms. Prodesse also operates a CLIA certified laboratory for testing services in the Midwest area. For more information about Prodesse and its products, call 888-589-6974 or go to www.prodesse.com.
Press Contact:
Andy Shrago, Chief Marketing Officer
Prodesse, Inc.
Phone: (262) 446-0700
Email: ashrago@prodesse.com